Advertisement
Advertisement

NAOV

NAOV logo

NanoVibronix, Inc. Common Stock

2.35
USD
-0.21
-8.40%
Apr 03, 15:55 UTC -4
Closed
exchange

After-Market

2.48

+0.13
+5.76%

NanoVibronix, Inc. Common Stock Profile

About

NanoVibronix, Inc. is a medical device company. The Company's products include WoundShield(TM), a patch-based therapeutic ultrasound device which facilitates tissue regeneration and wound healing; PainShield(R), a disposable patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures; UroShield(TM), an ultrasound-based product which is designed to prevent biofilm in urinary catheters; NanoVibronix, lightweight pump which allow contamination-free handling of infected wound exudate and enhanced patient mobility. NanoVibronix, Inc. is based in Melville, New York.

Info & Links

CEO

Brian Murphy

Headquarters

969 PRUITT AVE,
TYLER, TX 77569, UNITED STATES

Sector

Medical

Auditor

Zwick CPA, PLLC

Share holders

101

Employees

31

NanoVibronix, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

1.96M

Enterprise Value

1.21M

Enterprise Value/EBITDA(ttm)

-0.34

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

1.02

Price to Book(mrq)

0.57

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

55.90%

Operating Margin(ttm)

-93.80%

Profit Margin(ttm)

-183.94%

Return on Equity(ttm)

-101.17%

Return on Invested Capital(ttm)

-322.54%

Return on Assets(ttm)

-53.03%

Income Statement

Revenue(ttm)

2.56M

Revenue Per Share(ttm)

3.37

Gross Profit(ttm)

1.51M

EBITDA(ttm)3

-3.58M

Net Income Available to Common(ttm)

-3.71M

Diluted EPS(ttm)

-1.23

Share Statistics

Beta (5Y Monthly)

1.63

52-Week Change

-76.78%

S&P 500 52-Week Change

3.55%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

759.30K

Dividend Yield

0.00%

Float4

3.49M

% Held by Insiders

7.00%

% Held by Institutions

16.39%

Balance Sheet

Total Cash(mrq)

752.00K

Total Cash Per Share(mrq)

0.99

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

1.22%

Quick Ratio(mrq)

0.84%

Book Value Per Share(mrq)

1.65

Cash Flow

Operating Cash Flow Per Share(ytd)

-9.32

Free Cash Flow(ytd)

-2.52M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement